Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells

Cheuk Sing Choy, Chien Ming Hu, Wen Ta Chiu, Carlos Lam, Yih Ting, Shin Han Tsai, Tzu Chien Wang

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Sanguis Draconis (SD) is a kind of dragon's blood resin that is obtained from Daemomorops draco (Palmae). It is used in traditional medicine and has shown anti-inflammatory activity in some diseases. In this study, we examined the effects of Sanguis Dranonis ethanol extract (SDEE) on LPS-induced inflammation using RAW 264.7 cells. Our data indicated that SDEE inhibits LPS-stimulated NO, PGE2, IL-1β and TNF-α release, and iNOS and COX-2 expression. Furthermore, SDEE suppressed the LPS-induced p65 expression of NF-κB, which was associated with the inhibition of IκB-α degradation. We also found that the expression of HO-1 was significantly increased in RAW 264.7 cells by SDEE. These results suggest among possibilities of anti-inflammation that SDEE inhibits the production of NO and PGE2 by the down-regulation of iNOS and COX-2 gene expression via the suppression of NF-κB (p65) activation. SDEE can induce HO-1 over-expression in macrophage cells, which indicates that it may possess antioxidant properties. This result means that SEDD its anti-inflammatory effects in macrophages may be through a novel mechanism that involves the action of HO-1. Thus, SD could provide a potential therapeutic approach for inflammation-associated disorders.

Original languageEnglish
Pages (from-to)455-462
Number of pages8
JournalJournal of Ethnopharmacology
Volume115
Issue number3
DOIs
Publication statusPublished - Feb 12 2007

Fingerprint

Nitric Oxide Synthase Type II
Cyclooxygenase 2
Lipopolysaccharides
Ethanol
Inflammation
Dinoprostone
Anti-Inflammatory Agents
Macrophages
Traditional Medicine
Interleukin-1
RAW 264.7 Cells
dragon's blood
Down-Regulation
Antioxidants
Gene Expression

Keywords

  • Cyclooxygenase-2
  • Inducible nitric oxide synthase
  • Lipopolysaccharide
  • Nuclear factor-κB
  • Sanguis Draconis

ASJC Scopus subject areas

  • Pharmacology

Cite this

Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells. / Choy, Cheuk Sing; Hu, Chien Ming; Chiu, Wen Ta; Lam, Carlos; Ting, Yih; Tsai, Shin Han; Wang, Tzu Chien.

In: Journal of Ethnopharmacology, Vol. 115, No. 3, 12.02.2007, p. 455-462.

Research output: Contribution to journalArticle

@article{6703663cf0994a5890463a0166b11771,
title = "Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells",
abstract = "Sanguis Draconis (SD) is a kind of dragon's blood resin that is obtained from Daemomorops draco (Palmae). It is used in traditional medicine and has shown anti-inflammatory activity in some diseases. In this study, we examined the effects of Sanguis Dranonis ethanol extract (SDEE) on LPS-induced inflammation using RAW 264.7 cells. Our data indicated that SDEE inhibits LPS-stimulated NO, PGE2, IL-1β and TNF-α release, and iNOS and COX-2 expression. Furthermore, SDEE suppressed the LPS-induced p65 expression of NF-κB, which was associated with the inhibition of IκB-α degradation. We also found that the expression of HO-1 was significantly increased in RAW 264.7 cells by SDEE. These results suggest among possibilities of anti-inflammation that SDEE inhibits the production of NO and PGE2 by the down-regulation of iNOS and COX-2 gene expression via the suppression of NF-κB (p65) activation. SDEE can induce HO-1 over-expression in macrophage cells, which indicates that it may possess antioxidant properties. This result means that SEDD its anti-inflammatory effects in macrophages may be through a novel mechanism that involves the action of HO-1. Thus, SD could provide a potential therapeutic approach for inflammation-associated disorders.",
keywords = "Cyclooxygenase-2, Inducible nitric oxide synthase, Lipopolysaccharide, Nuclear factor-κB, Sanguis Draconis",
author = "Choy, {Cheuk Sing} and Hu, {Chien Ming} and Chiu, {Wen Ta} and Carlos Lam and Yih Ting and Tsai, {Shin Han} and Wang, {Tzu Chien}",
year = "2007",
month = "2",
day = "12",
doi = "10.1016/j.jep.2007.10.012",
language = "English",
volume = "115",
pages = "455--462",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells

AU - Choy, Cheuk Sing

AU - Hu, Chien Ming

AU - Chiu, Wen Ta

AU - Lam, Carlos

AU - Ting, Yih

AU - Tsai, Shin Han

AU - Wang, Tzu Chien

PY - 2007/2/12

Y1 - 2007/2/12

N2 - Sanguis Draconis (SD) is a kind of dragon's blood resin that is obtained from Daemomorops draco (Palmae). It is used in traditional medicine and has shown anti-inflammatory activity in some diseases. In this study, we examined the effects of Sanguis Dranonis ethanol extract (SDEE) on LPS-induced inflammation using RAW 264.7 cells. Our data indicated that SDEE inhibits LPS-stimulated NO, PGE2, IL-1β and TNF-α release, and iNOS and COX-2 expression. Furthermore, SDEE suppressed the LPS-induced p65 expression of NF-κB, which was associated with the inhibition of IκB-α degradation. We also found that the expression of HO-1 was significantly increased in RAW 264.7 cells by SDEE. These results suggest among possibilities of anti-inflammation that SDEE inhibits the production of NO and PGE2 by the down-regulation of iNOS and COX-2 gene expression via the suppression of NF-κB (p65) activation. SDEE can induce HO-1 over-expression in macrophage cells, which indicates that it may possess antioxidant properties. This result means that SEDD its anti-inflammatory effects in macrophages may be through a novel mechanism that involves the action of HO-1. Thus, SD could provide a potential therapeutic approach for inflammation-associated disorders.

AB - Sanguis Draconis (SD) is a kind of dragon's blood resin that is obtained from Daemomorops draco (Palmae). It is used in traditional medicine and has shown anti-inflammatory activity in some diseases. In this study, we examined the effects of Sanguis Dranonis ethanol extract (SDEE) on LPS-induced inflammation using RAW 264.7 cells. Our data indicated that SDEE inhibits LPS-stimulated NO, PGE2, IL-1β and TNF-α release, and iNOS and COX-2 expression. Furthermore, SDEE suppressed the LPS-induced p65 expression of NF-κB, which was associated with the inhibition of IκB-α degradation. We also found that the expression of HO-1 was significantly increased in RAW 264.7 cells by SDEE. These results suggest among possibilities of anti-inflammation that SDEE inhibits the production of NO and PGE2 by the down-regulation of iNOS and COX-2 gene expression via the suppression of NF-κB (p65) activation. SDEE can induce HO-1 over-expression in macrophage cells, which indicates that it may possess antioxidant properties. This result means that SEDD its anti-inflammatory effects in macrophages may be through a novel mechanism that involves the action of HO-1. Thus, SD could provide a potential therapeutic approach for inflammation-associated disorders.

KW - Cyclooxygenase-2

KW - Inducible nitric oxide synthase

KW - Lipopolysaccharide

KW - Nuclear factor-κB

KW - Sanguis Draconis

UR - http://www.scopus.com/inward/record.url?scp=37349053781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349053781&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2007.10.012

DO - 10.1016/j.jep.2007.10.012

M3 - Article

C2 - 18060707

AN - SCOPUS:37349053781

VL - 115

SP - 455

EP - 462

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

IS - 3

ER -